Cyterix Pharmaceuticals
San Francisco
About Cyterix Pharmaceuticals
Cyterix Pharmaceuticals, Inc., a privately held cancer therapeutics company, is engaged in the discovery and development of new classes of small molecule prodrugs with improved safety and efficacy over traditional drugs. The company's approach, based on a proprietary technology platform, uniquely enables the design of multiple classes of anticancer prodrugs that are selectively activated by extra-hepatic cytochrome P450 enzymes that are greatly over-expressed in a broad range of solid tumor and hematologic cancers, but not in normal tissues.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $16.5M
- Last round: Series Unknown (Jul 2012)
- Website: cyterix.com
- Phone: +1 415-865-2059
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/cyterix-pharmaceuticals-3562732 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.